Vincerx Pharma, Inc. (VINC) Misses Q1 EPS by 44c

Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q1 EPS of ($0.68), $0.44 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Premarket movers: Oracle surges on AI growth, ACV auctions jumps on $1.9B deal
• William Blair Reiterates Outperform Rating on SpaceX (SPCX)